News

Crohn’s disease is a chronic condition for which there is currently no satisfactory cure able to increase the quality of life for people who have Crohn’s disease. DBV

A total of 45 patients with mild to moderate ulcerative colitis are enrolled in the trial, which is designed to assess the safety, efficacy, pharmacokinetics and effects on

In 2011, the companies have signed a worldwide agreement to develop and market tivozanib outside of Asia for the treatment of a broad range of cancers As part

Under the deal, Moberg Pharma has been granted Menarini Asia-Pacific the exclusive rights to market and sell Kerasal Nail in eight Southeast Asian countries. The deal builds on

The manufacturing plant was previously approved by the European Medicines Agency (EMA) for production of VPRIV drug substance. National Gaucher Foundation CEO and executive director Rhonda Buyers said,

Ben Venue Laboratories has initiated this voluntary recall on 14 February 2014 and has informed the US Food and Drug Administration (FDA) of its actions. The company is

The acquisition is part of Medifirst Solutions plan to increase its internal technology infrastructure and add technical and digital services and expertise to its internal business operations. Medifirst

Forest has notified the US Food and Drug Administration of this decision. The oral solution of NAMENDA and once-daily NAMENDA XR (memantine HCl) extended-release capsules will continue to

The technology is being announced during the Advances in Genome Biology & Technology (AGBT) conference, which is recognized throughout the sequencing community as a cornerstone for the discussion